Literature DB >> 54364

Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.

P R Larsen.   

Abstract

To evaluate the potential contribution of thyroidal secretion to the relative excess of triiodothyronine (T3) production in hyperthyroidism and to investigate the effects of treatment, iodine (127I), T3 and thyroxine (T4) were measured in digests of thyroid tissue obtained at surgery from 13 patients with Graves' disease. In 11 normal human thyroid glands, 127I content was 630 +/- 60 (all values mean +/- SE in mug/ wet weight) T4, 254 +/- 39 and T3 21 +/-3. The T4I was 26 +/- 3% of the total iodine and the molar ratio T4/T3 was 11 +/- 1. The 13 patients with Graves' disease were divided into three groups. Eleven were clinically euthyroid (Groups I and II) and had received either iodide or iodide plus a thiourea derivative before surgery. Two subjects (Group III) received only propranolol. In Group I (n = 8), mean thyroidal 127I content was 320 +/- 50, T4 was 115 +/- 9 and T3 22 +/- 4. The molar ratio T4/T3 was 5.9 +/- 1 and T4I was 26 +/- 2% of the total. Group II patients (3) had the lowest preoperative serum T4 (less than 2.5 mug/dl) and T3 (less than ng/dl) concentrations with TSH elevated in only one (7 muU/ml). Thyroidal 127I was 100 +/- 26, T49 +/- and T3 1.3 +/- 0.3. The % T4I was 5 +/-2. The two chemically hyperthyroid subjects had a mean tissue 127I of 450; T4, 295 and T3, 56, the T4/T3 ratio was 4.5 and % T4I was 42. There was no correlation between tissue 127I and T4/T3 within either the normal or Graves' disease group. Since adequate clinical and chemical control of hyperthyroidism with antithyroid drugs and iodine was attained in the 8 Group I subjects without a decrease in the % T4I or T3I below that of normal thyroids, it suggests that inhibition of iodotyrosine coupling is not required for this effect. The % T4I was below normal only in patients with marked suppression of serum T4 and T3 concentraions. The lack of correlation between tissue 127I and T4/T3 ratio in the treated patients suggests that the lower T4/T3 ratio in Graves' thyroids is independent of intrathyroidal iodine concentrations. This hypothesis is strengthened by the similarly low T4/T3 ratio in untreated subjects with near normal tissue 127I content. Assuming that the thyroid hormones are secreted in the ratios present in these digests, one can estimate that direct secretion by the thyroid could contribute most, of not all, of the excess T3 production in Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 54364     DOI: 10.1210/jcem-41-6-1098

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Relationship between the dimerization of thyroglobulin and its ability to form triiodothyronine.

Authors:  Cintia E Citterio; Yoshiaki Morishita; Nada Dakka; Balaji Veluswamy; Peter Arvan
Journal:  J Biol Chem       Date:  2018-02-12       Impact factor: 5.157

2.  De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone.

Authors:  Cintia E Citterio; Balaji Veluswamy; Sarah J Morgan; Valerie A Galton; J Paul Banga; Stephen Atkins; Yoshiaki Morishita; Susanne Neumann; Rauf Latif; Marvin C Gershengorn; Terry J Smith; Peter Arvan
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

3.  Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.

Authors:  M Izumi; P R Larsen
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

4.  Development of thyroid function between VI-IX month of fetal life in humans.

Authors:  A Costa; V De Filippis; M Panizzo; G Giraudi; E Bertino; R Arisio; M Mostert; G Trapani; C Fabris
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

5.  Thyroid function tests during carbimazole therapy.

Authors:  D L Scott; D J Tymms; M A Taylor; C Chapman
Journal:  Postgrad Med J       Date:  1980-12       Impact factor: 2.401

6.  Agoitrous Graves' Hyperthyroidism with Markedly Elevated Thyroid Stimulating Immunoglobulin Titre displaying Rapid Response to Carbimazole with Discordant Thyroid Function.

Authors:  Yin Chian Kon; Brenda Su Ping Lim; Yingshan Lee; Swee Eng Aw; Yoko Kin Yoke Wong
Journal:  J ASEAN Fed Endocr Soc       Date:  2020-11-19

Review 7.  The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it.

Authors:  Christina Wenzek; Anita Boelen; Astrid M Westendorf; Daniel R Engel; Lars C Moeller; Dagmar Führer
Journal:  Eur J Endocrinol       Date:  2022-03-23       Impact factor: 6.558

8.  Clinical significance of hepatic function in Graves disease with type 2 diabetic mellitus: A single-center retrospective cross-sectional study in Taiwan.

Authors:  Yi-Wei Lee; Yan-Yu Lin; Shuen-Fu Weng; Chung-Huei Hsu; Chen-Ling Huang; Yu-Pei Lin; Yu-Shan Hsieh
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

9.  Severe Hypothyroxinemia in a Young Adult with Carbimazole-Treated T3-Predominant Graves' Hyperthyroidism, Reversed with L-Thyroxine Loading Immediately Post-Total Thyroidectomy.

Authors:  Brenda Chiang; Yin Chian Kon
Journal:  J ASEAN Fed Endocr Soc       Date:  2021-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.